Skip to main content
Image
rhondalyn-bomkamp

Rhondalyn Bomkamp

RN, BSN, MBA

Rhondalyn Bomkamp, Principal, Content and Evidence, Leica Biosystems, is an accomplished Director/Nurse Leader with a proven track record of effectively managing complex projects and health system performance improvement initiatives. As a registered nurse, she has experience in Quality and Patient Safety and Project Management/Development in the oncology, cardiac and intensive care arenas. She has strong clinical knowledge and management experience with the ability to recognize opportunities for improvement, coordinate the work of many areas and develop collaborative relationships with diverse groups to facilitate the implementation of change.

Published Pieces by Rhondalyn Bomkamp

Editorial (Knowledge Pathway)

Pathologists use various stains to help make their diagnoses. One of the categories of stains is called special stains and refers to a technique where dyes or chemicals are used to identify specific cell structures or components present within the submitted sample. The pathologist can use these particular special stains to confirm or categorize the potential diagnoses.

Editorial (Knowledge Pathway)

Connective tissue plays an essential role in the human body by holding together, protecting, supporting, and joining organs to tissues. This editorial describes the categories of connective tissue, the types of connective tissue diseases, and the diagnosis of connective tissue diseases.

Training Resources (Knowledge Pathway)

The responsibility of the clinical laboratory is to provide quality patient diagnostics. However, the environment in which this work occurs contains health and safety risks where workers must remain vigilant. This article will review safety precautions in the laboratory.  

Editorial (Knowledge Pathway)

Precision and personalized medicine are terms used interchangeably. This approach is advancing rapidly and will change the way clinicians are practicing medicine. 

In partnership with the National Consortium of Breast Centers (NCBC), Leica Biosystems’ Process & Solution Optimization team worked with several hospitals with the goal to improve the quality and efficiencies of their breast programs. Through this work, the team identified common barriers and improvement opportunities.

In partnership with the National Consortium of Breast Centers (NCBC), Leica Biosystems’ Process & Solution Optimization team worked with several hospitals with the goal to improve the quality and efficiencies of their breast programs. Through this work, the team identified common barriers and improvement opportunities.

Leica Biosystems working in partnership with Southern Ohio Medical Center (SOMC), conducted process assessments to analyze the timeliness treatment for breast cancer patients. We identified a lack of standardized processes for conduction of imaging services and elongated time to diagnosis. The Breast Imaging and Reporting Data System (BI-RADs) is the standardized method to record findings on imaging studies.

Leica Biosystems working in partnership with Southern Ohio Medical Center (SOMC), conducted process assessments to analyze the timeliness treatment for breast cancer patients. We identified a lack of standardized processes for conduction of imaging services and elongated time to diagnosis. The Breast Imaging and Reporting Data System (BI-RADs) is the standardized method to record findings on imaging studies.

Southern Ohio Medical Center (SOMC) is a community hospital in Portsmouth, Ohio. Review of data pertaining to breast care delivery demonstrated opportunities for improvement. Analysis of the cadence of care processes across departments demonstrated delays in care and outmigration potential. One quality study demonstrated 10% of patients did NOT select SOMC for surgical intervention post biopsy.

Southern Ohio Medical Center (SOMC) is a community hospital in Portsmouth, Ohio. Review of data pertaining to breast care delivery demonstrated opportunities for improvement. Analysis of the cadence of care processes across departments demonstrated delays in care and outmigration potential. One quality study demonstrated 10% of patients did NOT select SOMC for surgical intervention post biopsy.